O'Neill Gilmore Neil
SEC CIK 1742084 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | CEO, Dir | 243.2K | — | $1.02M | 15 | 2022-06-02 | 2026-09-03 |
Most active insiders at EDIT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Neill Gilmore Neil | CEO, Dir | — | $80.0K |
| 2 | Burkly Linda | EVP, CSO | — | $20.3K |
| 3 | Parison Amy | SVP, CFO | — | $6,327 |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 16:22 | 2026-09-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $3.04 | -5,124 | 243.2K | -2% | -$15.6K |
| T | 2026-06-05 16:33 | 2026-06-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $2.70 | -15.4K | 248.3K | -6% | -$41.5K |
| 2026-03-04 | 2026-03-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $2.02 | -5,394 | 263.7K | -2% | -$10.9K | |
| 2025-12-04 | 2025-12-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $2.15 | -5,603 | 269.1K | -2% | -$12.0K | |
| 2025-09-04 | 2025-09-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $2.60 | -5,592 | 274.7K | -2% | -$14.5K | |
| 2025-06-04 | 2025-06-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $1.72 | -15.2K | 280.3K | -5% | -$26.1K | |
| 2025-03-05 | 2025-03-04 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $1.71 | -16.6K | 295.5K | -5% | -$28.4K | |
| 2024-12-05 | 2024-12-03 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $2.08 | -1,618 | 312.1K | -0.5% | -$3,365 | |
| 2024-09-06 | 2024-09-04 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $3.42 | -1,555 | 313.7K | -0.5% | -$5,318 | |
| 2024-06-06 | 2024-06-04 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $5.50 | -12.2K | 315.3K | -4% | -$67.1K | |
| DM | 2024-03-05 | 2024-03-02 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | A - Grant | $0.00 | +275.1K | 260.9K | New | $0 |
| D | 2024-03-05 | 2024-03-05 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $9.42 | -77.8K | 327.5K | -19% | -$733.1K |
| 2023-06-07 | 2023-06-05 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $9.50 | -6,486 | 130.2K | -5% | -$61.6K | |
| D | 2023-03-06 | 2023-03-02 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | A - Grant | $0.00 | +50.0K | 136.7K | +58% | $0 |
| D | 2022-06-06 | 2022-06-02 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO, Dir | A - Grant | $0.00 | +86.7K | 86.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations